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Increased Severity of HSV-1 Keratitis and Mortality in
Mice Lacking the 2–5A-dependent RNase L Gene
Xiaodong Zheng,1,3 Robert H. Silverman,2 Aimin Zhou,2 Tomoko Goto,1,3
Byoung Se Kwon,1 Herbert E. Kaufman,1 and James M. Hill1
PURPOSE. The 29,59-oligoadenylate-dependent RNase L gene
functions in the interferon-inducible RNA decay pathway
known as the 2–5A system. The purpose of this study was to
determine whether the absence of this gene affects the patho-
genesis of herpes simplex virus type 1 (HSV-1) ocular infection
in the mouse.
METHODS. HSV-1 (strain McKrae) was applied bilaterally to
unscarified corneas of RNase L–null mice and congenic con-
trols. To evaluate the severity of herpetic keratitis, slit lamp
examinations (SLE) were performed every other day for 14
days. To study corneal histology and apoptosis, HSV-1–inocu-
lated RNase-L-null and congenic control mice, as well as mock-
inoculated mice (apoptosis negative control), were killed at 6
and 18 hours postinoculation (PI). Uninoculated mice that
underwent corneal scarification (apoptosis positive control)
were killed 2 hours after scarification. Eyes were dissected and
the corneas processed for light and transmission electron mi-
croscopy and the TUNEL assay.
RESULTS. In comparison with the congenic control mice, RNase
L–null mice showed significantly more severe herpetic keratitis
(PI day 8, SLE score, mean 6 SEM: 3.27 6 0.10 vs. 2.34 6 0.06;
P , 0.001) and significantly higher mortality (PI day 14, 70%
vs. 20%; P , 0.001). Few apoptotic cells were seen in HSV-1–
infected RNase L–null mice, although DNA fragmentation con-
sistent with apoptosis was detected in the corneas of congenic
control mice 6 and 18 hours after HSV-1 inoculation and in
uninfected mice with scarified corneas. Signs of apoptosis
were not present in the mock-infected corneas. Electron mi-
croscopic evidence of keratocytic apoptosis was detected only
in the uninfected scarified corneas and the HSV-1–infected
congenic control corneas.
CONCLUSIONS. The increased severity of ocular disease and in-
creased mortality in the RNase L–null mice provides evidence,
for the first time, that the 2–5A system contributes to protec-
tion during ocular herpetic infection. The reduced frequency
of apoptosis in these mice suggests that one possible mecha-
nism for this protective effect could be the induction of
apoptosis in corneal cells as a means of reducing the spread
of infectious virus. (Invest Ophthalmol Vis Sci. 2001;42:
120–126)
Herpes simplex virus type 1 (HSV-1) infection is one of themost intensively investigated of all infectious ocular dis-
eases. Corneal infection with HSV-1 represents a significant
clinical problem for its potential to cause blindness.1,2 In
higher vertebrates, many cellular strategies have been devel-
oped to defend against viral invasion. The interferon (IFN)
family of cytokines is known to be important in host defenses
to viral infection, and the IFN-induced antiviral pathways have
been investigated intensively.3–9 The evolution of intercellular
communication has provided infected cells with the ability to
signal uninfected cells that a virus had invaded the organism.
Thus some cells undergo apoptosis or programmed cell death
in the face of viral infection, a process that could be used by
the host to limit viral invasion.3,9–12 Similarly, HSV-1 infection
of the corneal epithelium has been shown to induce apoptosis
of underlying keratocytes.13 Specific viral proteins have also
been suggested to be involved in anti-apoptotic effects14,15 or
in negating antiviral functions of the host innate immune re-
sponse (i.e., IFN).16,17
Levels of IFN-b and IFN-g have been shown to be elevated
in the cornea after viral infection.2,18-20 Involvement of the
2–5A system in the IFN-initiated antiviral scenario has been
well elucidated.3,4,7–12,21–31 In brief, IFN signals cells, leading
to an increase in levels of the family of 29,59-oligoadenylate
synthetases (OAS). Double-stranded RNA derived from viral
replication intermediates and viral transcription activates OAS.
Activated OAS converts ATP into unusual, short 29-59 linked
oligoadenylates called 2–5A. The 2–5A binds to and activates
RNase L, cleaving single-stranded RNA with moderate specific-
ity for sites 39 of UpUp and UpAp sequences. RNase L rapidly
degrades both viral and cellular RNA, thus crippling the cell’s
ability to support viral replication. Involvement of the 2–5A
system in the antiviral effect of IFN by means of induction of
apoptosis has been reported in cell culture experiments as well
as in an animal model containing a targeted disruption in the
gene encoding RNase L (RNase L–null mouse).8,9,11,24,28,30,31
However, in vivo evidence for the antiviral function of the
2–5A system is limited to studies of encephalomyocarditis
virus.24 To our knowledge, there has been no report showing
that the 2–5A system mediates an antiviral effect by induction
of apoptosis in response to HSV-1 infection in any animal
model. In this study, we used RNase L–null mice and congenic
controls to investigate the possibility that the 2–5A system




Six- to 8-week-old RNase L–null mice and congenic control mice were
used. The genetic background of the RNase L–null and congenic
control mice was 129/o1a 3 Swiss black.24 The construction of the
RNase L gene-targeting vector and the generation of RNase L–null mice
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have been described.24 The RNase L–null mice and the congenic
control mice were not visually distinguishable. All animals were han-
dled in accordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
Cells and Virus
HSV-1 strain McKrae was propagated on primary rabbit kidney cell
monolayers in minimal essential medium (GIBCO, Gaithersburg, MD)
with 5% fetal bovine serum and titered on African green monkey
kidney cells.
Mouse Inoculation
Each RNase L–null mouse and congenic control mouse was anesthe-
tized with 150 ml of a mixture of ketamine (10 mg/ml) and xylazine (5
mg/ml). Each eye received 5 ml of a viral suspension containing either
2.5 3 105 pfu or 2.5 3 107 pfu of HSV-1 strain McKrae. The cornea was
not scarified. Eyelids were closed and massaged gently for 20 seconds
with care taken to avoid leakage of the inoculum. Mock inoculation
was done by inoculating the cornea with cell culture medium in the
same manner.
Slit Lamp Examination
Slit lamp examinations (SLE) with 0.1% fluorescein staining were per-
formed in a masked manner before inoculation and every other day for
14 days postinoculation (PI). Epithelial lesions and stromal involve-
ment were graded on a scale of 0 to 4, as follows: 0, normal cornea; 0.5,
punctate lesions; 1.0, dendritic lesions; 1.5, geographic lesions with
stromal edema; 2.0, stromal involvement, pupillary iris visible; 3.0,
stromal involvement, pupillary iris invisible; and 4.0, severe stromal
keratitis, peripheral iris invisible. Mean disease scores (6 SEM) were
calculated for each group on each observation day (PI days 2, 4, 6, 8,
10, 12, and 14).
Experimental Design
To study the clinical manifestations, groups of age- and sex-matched
RNase L–null and congenic control mice were inoculated bilaterally
with HSV-1 strain McKrae. The severity of herpetic corneal lesions was
monitored by SLE, and mortality was recorded.
To analyze apoptosis, six each of RNase L–null and congenic con-
trol mice were inoculated bilaterally with HSV-1 (2.5 3 105 pfu per
eye), without corneal scarification. Six and 18 hours later, mice were
killed, the eyes dissected, and the corneas processed for DNA fragmen-
tation detection (TUNEL assay) and light and transmission electron
microscopy (TEM). Corneas of two congenic control mice scarified
with a sterile 30-gauge needle in a 5 3 5 line crosshatch pattern served
as apoptotic signal positive controls. Both mice were killed 2 hours
after corneal scarification because this time point has been reported to
be the peak of occurrence of keratocytic apoptosis after corneal
wounding.32 Two additional congenic control mice received cell cul-
ture medium (mock inoculation). One mock-infected mouse was killed
at 6 hours after inoculation and one at 18 hours, along with the
HSV-1-infected mice, to serve as apoptotic signal negative controls.
DNA Fragmentation Detection
In situ DNA fragmentation detection was performed by the TUNEL
assay. Whole mouse eyes were removed; all right eyes were immedi-
ately embedded in optimal cutting temperature (OCT) compound
(Miles Laboratories, Elkhart, IN), and frozen in liquid nitrogen. Twenty
7-mm thick sections (every fifth section of approximately 100 sections
from each eye) that extended transversely across the central cornea of
the mouse eye were collected and stained with the peroxidase-
based TUNEL method, according to the manufacturer’s instructions
(ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit; Intergen,
Purchase, NY). Twenty sections were stained from each corneal spec-
imen; 60 sections were stained for each group at each time point (6
hours and 18 hours). In general, the average numbers of corneal cells,
as evidenced by counterstaining of the nuclei, were approximately the
same on each section of cornea for the two groups (data not shown).
The TUNEL-positive cells were readily recognized by dark brown
labeling. The numbers of apoptotic cells in 10 nonoverlapping, full
corneal thickness, randomly selected columns were counted in a
masked fashion for each specimen.13 The diameter of each column was
the 4003 field of the microscope.
Light and Transmission Electron Microscopy
All left eyes from mice killed as described previously were fixed in
Karnovsky fixative (3% gluteraldehyde, 1% paraformaldehyde) over-
night. The corneas were then dissected, fixed again in Karnovsky
fixative for an additional 24 hours, postfixed in osmium tetroxide,
dehydrated with ethanol and propylene oxide, and embedded in a
mixture of Araldite 502 and Embed 812 (EMS, Fort Washington, PA).
Semithin sections (0.5 mm) were initially stained with 1% toluidine
blue and examined by light microscopy. Finally, thin sections (70 nm)
were cut, stained with 2% uranyl acetate and lead citrate solutions, and
examined by transmission electron microscopy (Zeiss TEM 10C/CR;
Oberkochen, Germany) at 100 kV.
Statistical Analysis
Mortality and slit lamp scores for the RNase L–null and congenic
control mice were analyzed separately. Mortality was analyzed with
Kaplan–Meier analysis; differences between the two curves were com-
pared using the Mantel–Haenszel procedure.33 Differences between
the slit lamp scores were evaluated using the Student’s t-test on the
scores for the RNase L–null and congenic control mice. P , 0.05
defined significance. All data analyses were performed with computer
software (Statistical Analysis System; SAS Institute, Cary, NC).
RESULTS
Clinical Observations
Two sets of experiments were performed to examine the
characteristics of acute HSV-1 corneal infection in RNase L–null
and congenic control mice. In the first experiment, mice inoc-
ulated with HSV-1 at a high titer (2.5 3 107 pfu per eye) had
high mortality. Only 3 of 10 RNase L–null mice survived to PI
day 8, which represented the peak of severity of the corneal
disease, whereas 6 of 10 congenic control mice survived to this
time point. However, there was no significant difference in the
severity of disease between the two groups: mean (6 SEM) SLE
scores on PI day 8 for the three surviving RNase L–null mice
and the six surviving congenic control mice were 3.67 6 0.11
and 3.33 6 0.18, respectively (P 5 0.815, Table 1).
TABLE 1. Slit Lamp Examination of Herpetic Corneal Lesions






1 3.67 6 0.11‡ 3/10 3.33 6 0.18 6/10 0.815
2 3.27 6 0.10 12/30 2.36 6 0.06 26/30 ,0.001
In Experiment 1, 10 RNase L-null and 10 congenic control mice
were inoculated with 2.5 3 107 pfu of HSV-1 strain McKrae. In
Experiment 2, three separate experiments were performed, each in-
volving 10 RNase L-null and 10 congenic control mice inoculated with
a 100-fold lower viral titer (2.5 3 105 pfu). Herpetic corneal lesions
were scored (Scale 0–4) by slit lamp biomicroscopy every other day
for a period of 14 days. The results of the three separate experiments
were similar, and the data were combined.
* S 5 Number of mice surviving on PI day 8/total number inocu-
lated.
† Student’s t-test.
‡ Mean 6 SEM.
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In the second set of experiments, a 100-fold lower viral titer
(2.5 3 105 pfu) was used. After inoculation, the corneas dis-
played punctate epithelial lesions and small dendritic lesions.
On PI day 4, the dendritic appearance of the corneal lesions
became typical, and stromal involvement was observed, mostly
in the RNase L–null mice.
This set of experiments consisted of three separate exper-
iments with 10 mice in each group in each experiment, for a
total of 30 RNase L–null mice and 30 congenic control mice
inoculated. All three of the experiments produced similar re-
sults, and the data from all three experiments were combined.
In contrast to the results of the first experiment, the mean
severity of the corneal lesions in the surviving animals on PI
day 8 (the peak of corneal disease) was significantly greater in
the RNase L–null mice (N 5 12/30) than in the congenic
controls (N 5 26/30) (mean 6 SEM SLE scores: 3.27 6 0.10 vs.
2.36 6 0.06; P , 0.001; Table 1, Fig. 1A).
Mortality was significantly greater in the RNase L–null mice
than in the congenic controls. By PI day 8, 18 of 30 (60%)
RNase L–null mice had died, whereas only 4 of 30 (13.3%)
congenic control mice had died (P , 0.001, Fig. 1B). Further-
more, both mortality and the severity of ocular disease were
significantly greater in the RNase L–null mice, compared with
the congenic controls, at the end of the observation period (PI
day 14: mortality, 70% vs. 20%; mean 6 SEM SLE scores, 2.69 6
0.08 vs. 0.6 6 0.05; P , 0.001for both comparisons).
To determine the effect of the differential mortality in the
two groups, the SLE scores were analyzed in two ways: all
animals (scores from all animals alive at each time point) and
surviving animals only (scores from only the animals that sur-
vived to the end of the observation period). As seen in Figure
1A, the means for all animals and surviving animals were
indistinguishable.
TUNEL Assay
Apoptotic cells were scant to nonexistent in the corneas of
RNase L–null mice infected with HSV-1. TUNEL-positive cells
were not found in the corneal sections 6 hours after inocula-
tion (Fig. 2A) and only a few TUNEL-positive epithelial cells
(0.8 6 0.6 per 4003 field) were detected in a small number of
sections (4 of 60) at 18 hours (Fig. 2B). Apoptotic keratocytes
were not seen. In contrast, the HSV-1-infected congenic con-
trols showed 2.9 6 1.3 TUNEL-positive cells per 4003 field,
mostly in the epithelial cell layer, at 6 hours (Fig. 2C) and 5.8 6
1.2 apoptotic cells per field, located in both the epithelium and
anterior stroma, at 18 hours after inoculation (Fig. 2D). The
differences in the counts of TUNEL-positive cells between the
RNase L–null and congenic control mice were significant at 6
(P 5 0.004) and 18 hours (P , 0.001) after inoculation. At 18
hours, the percentage of apoptotic cells in the congenic con-
trols ranged from approximately 15% to 30%, based on each
field containing 20 to 40 corneal cells. The apoptotic cells were
located, for the most part, in the immediate perimeter around
or directly under the infected corneal surface, indicating the
possible protective function of apoptosis.
The positive controls (corneal scarification) showed apo-
ptosis in both the epithelium and anterior stroma (6.2 6 1.1
TUNEL-positive cells per 4003 field at 2 hours after scarifica-
tion; Fig. 2E), similar in amount to that seen in the HSV-1-
infected congenic controls at 18 hours after inoculation (5.8 6
1.2; P 5 0.072). The negative controls (mock infection)
showed no apoptotic cells (Fig. 2F).
Histology
Microscopic evidence of epithelial damage indicative of HSV-1
replication was not found in either the RNase L–null corneal
sections or the congenic control sections obtained 6 hours
FIGURE 1. Severity of herpetic corneal lesions and mortality in RNase
L–null mice and congenic controls. (A) Means (6 SEM) of slit lamp
examination scores (scale 0 to 4) combined from three separate ex-
periments, each involving 10 mice inoculated with 2.5 3 105 pfu/eye
of HSV-1 McKrae and examined by slit lamp biomicroscopy every other
day for 14 days, plotted versus PI day. Solid symbols represent data
from all surviving mice at each observation point (N 5 30, 22, 18, 12,
10, 9, and 9 RNase L–null mice and 30, 30, 28, 26, 25, 24, and 24
congenic control mice on PI days 2, 4, 6, 8, 10, 12, and 14, respec-
tively). Open symbols represent data only from the mice that survived
to the end of the observation period (day 14; 9 RNase L–null mice and
24 congenic controls). (B) Percent mortality of the two groups of mice
during acute HSV-1 infection.
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after inoculation. By 18 hours, microscopic epithelial damage
was recognized in 8 of 60 (13.3%) RNase L–null sections and 2
of 60 (3.3%) congenic control sections (P 5 0.034). Epithelial
damage was not found in negative control (mock inoculation)
corneas. All positive control (corneal scarification) corneas
showed epithelial layer damage caused by needle scarification
(data not shown).
Areas of sections with evidence of epithelial injury detected
by light microscopy (if no epithelial injury, randomly selected
areas) were examined by TEM for evidence of apoptosis in
FIGURE 2. Corneal apoptosis detection by the TUNEL assay. (A) HSV-1–infected RNase L–null mouse cornea 6 hours after inoculation. DNA
fragmentation in situ consistent with apoptosis (dark brown staining) is not detected in either the epithelial layer or the underlying stromal
keratocytes. (B) RNase L–null mouse cornea 18 hours after inoculation. Only a few apoptotic epithelial cells are seen (arrows). (C) HSV-1–infected
congenic control mouse corneal epithelial cell layer 6 hours after infection. Greater numbers of apoptotic epithelial cells are visible (arrows). (D)
HSV-1–infected congenic control mouse corneal epithelial cell layer 18 hours after infection. Both epithelial cells (long arrows) and anterior
stromal keratocytes (short arrows) show evidence of DNA fragmentation. (E) Positive control cornea (scarification only) 2 hours after scarification.
Apoptotic cells are visible in the epithelium (long arrows) and stroma (short arrows). (F) Mock-infected negative control mouse cornea.
TUNEL-positive cells are not found. Magnification, 3400.
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underlying stromal keratocytes. Signs of apoptosis were not
seen in the mock-infected corneas (Fig. 3A). Keratocytes in the
HSV-1-infected congenic control corneas (18 hours) and the
uninfected scarified control corneas (2 hours) showed apopto-
tic changes mostly in the anterior stroma (Figs. 3B and 3C).
Approximately 5% of the keratocytes underwent changes char-
acteristic of apoptosis, which include chromatic condensation,
chromatic fragmentation, and cellular blebbing with formation
of membrane-bound cell fragments. No apoptotic keratocytes
were seen in the HSV-1-infected RNase L–null mouse corneas
(Fig. 3D).
DISCUSSION
The 2–5A system has been extensively investigated for its
involvement in the antiviral effect of IFN by means of induction
of apoptosis in vitro.8,9,11,24,28,30,31 In vivo study of the antivi-
ral effect of the 2–5A system has been reported for encepha-
lomyocarditis virus.24 The IFN family of cytokines is believed to
play an important role in the clearance of virus from the eye.
However, the molecular mechanism underlying the IFN-medi-
ated antiviral effect in ocular HSV-1 infection is not well
known. Our current experiments were undertaken to test our
hypothesis that the 2–5A system plays a role in the antiviral
effect of IFN in the HSV-1–infected mouse eye by initiating
keratocytic apoptosis.
Our clinical observations revealed that in comparison with
the congenic controls, mice lacking the RNase L gene had
exacerbated herpetic corneal lesions and increased mortality
after HSV-1 infection. In the first set of experiments, we used
a high viral titer (2.5 3 107 pfu per eye) to inoculate the mice.
Although the mortality for RNase L–null mice was higher than
that of congenic controls about halfway through the observa-
tion period, there was no significant difference in the severity
of herpetic corneal lesions between the two groups at that
time, possibly because of the small number of survivors avail-
able for evaluation. Also, the high dose of HSV-1 can perhaps
override the 2–5A system in the congenic controls, that is, the
virus may have gained a substantial foothold before enough
cells were able to establish an inhibitory state. When a 100-fold
lower viral titer was used in the second set of experiments, the
severity of corneal disease and mortality were significantly
greater in the RNase L–null mice, compared with the congenic
controls. Also, the RNase L–null mice developed more severe
conjunctivitis, blepharitis, and viral endophthalmitis in com-
parison with the congenic control mice (data not shown).
FIGURE 3. Transmission electron microscopic studies of keratocytes. (A) A mock-infected (negative control) cornea showing normal keratocytes
and regular chromatin. (B) Two hours after corneal scarification, a positive control (scarification only) cornea shows signs of apoptosis, including
cellular blebbing and numerous membrane-bound structures in a shrinking keratocyte (small arrows), as well as a keratocyte with a dramatically
diminished cell volume (large arrow), in the superficial stroma. (C) At a very early stage of corneal infection (18 hours), a keratocyte in the anterior
stroma of an HSV-1–infected congenic control mouse cornea shows dense chromatin condensation (large arrow) along the nuclear membrane
associated with cellular blebbing (small arrows), with reduced cytoplasm, indicative of apoptosis. (D) At the same early stage of corneal infection
(18 hours), an anterior stromal keratocyte in an HSV-1–infected RNase L–null mouse cornea shows no signs of apoptosis, with normal nuclear
morphology and cytoplasmic volume. Magnification, 36000.
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These findings demonstrate that the RNase L–null mice had
significantly increased susceptibility to HSV-1, indicating that
the absence of RNase L directly or indirectly increased viral
pathogenesis and mortality during acute infection.
To study the underlying pathogenesis of the observed clin-
ical features, we analyzed HSV-1–induced apoptosis in the
cornea at very early stages of infection. Six hours after viral
inoculation, signs of corneal epithelial lesions were not evident
in either the RNase L–null mice or the congenic control mice.
However, apoptotic cells could already be detected in the
corneas of HSV-1–infected congenic control mice, suggesting
that the signaling process mediating cell death precedes the
microscopic epithelial damage caused by viral replication.
Eighteen hours after inoculation, a few corneal epithelial le-
sions were noted in the congenic controls, whereas signifi-
cantly more lesions were seen in the RNase L–null mouse
corneas, indicating the early onset of HSV-1 epithelial effects in
the vulnerable RNase L–null mice. Nevertheless, the RNase
L–null corneas had significantly fewer apoptotic cells than the
congenic control corneas, and those few cells were found only
in the epithelial layer; in the congenic control corneas, apo-
ptotic cells were detected in both the epithelial layers and the
anterior stroma. Although we did not directly determine HSV-1
distribution in the cornea, our TUNEL assay and electron mi-
croscopic results showed that most of the apoptotic kerato-
cytes were located beneath the HSV-1–infected epithelial area
(as evidenced by epithelial damage), suggesting a protective
role for apoptosis in HSV-1–infected corneas.13 As a defense
mechanism, corneal cells are signaled to undergo apoptosis to
prevent further spread of HSV-1 to the deeper stroma as well as
higher levels of replication in the epithelium, followed by
retrograde neuronal transport to the brain, causing death.
Therefore, the significantly reduced apoptosis in the corneas of
RNase L–null mice correlates with a decreased ability to resist
HSV-1 infection, leading to increased severity of herpetic ker-
atitis and high mortality.
The anti–HSV-1 potential of the 2–5A system has been
studied in vitro. Fujihara et al.34 reported that introduction of
2–5A suppressed HSV-1 syncytium formation in BHK cell cul-
tures and prevented the lethal effect of HSV-2 in infected
guinea pigs. Cayley et al.35 showed that HSV can induce RNase
L inhibitors (2–5A–related compounds) and that RNase L acti-
vation, as determined by rRNA cleavage, was minimal in IFN-
treated, HSV-infected Chang cells. However, the possibility
exists that early, localized activation of RNase L, not detected
by the methods used, could be important. Khabar et al.36
reported that the absence of the PKR gene did not compromise
the anti–HSV-1 activity of IFN in mouse embryo fibroblasts.
However, when both the PKR gene and the RNase L gene were
absent, the anti–HSV-1 activity of IFN was reduced by about
fivefold, indicating that PKR and RNase L cooperate in some
way to provide the anti–HSV-1 effect of IFN.
Other mechanisms, aside from apoptosis induction by
RNase L, cannot be ruled out. For example, the activation of
RNase L in infected cells could simply halt the infection with-
out requiring induction of apoptosis. Also, it is possible that
both apoptosis and another mechanism are involved. In addi-
tion, effects of RNase L on cytokine production and MAPKs
that could be responsible for enhanced innate or adaptive
immune responses against HSV-1 have been reported by Ior-
danov et al.37
In another study, intracerebral inoculation of the KOS strain
of HSV-1 was lethal for both wild type and RNase L–knockout
mice within 8 to 10 days.17 Therefore, the effect of RNase L is
no longer observed when the ocular route of infection is
bypassed. These results support the idea that the antiviral
function of RNase L is to suppress the spread of HSV-1 through
apoptosis. However, alternative explanations, including differ-
ences in viral doses and virus strains, are also possible.
In summary, our data show that mice lacking RNase L have
significantly increased susceptibility to ocular HSV-1 infections.
Our study provides the first in vivo evidence that the 2–5A
system could be important for controlling viruses other than
picornaviruses (such as encephalomyocarditis virus). Alterna-
tive possibilities, such as contributions from unknown genetic
differences in the RNase L–null mice, cannot be completely
ruled out, however. Further experiments, including immuno-
pathologic studies of ocular and brain tissues and determina-
tion of local and systemic immune responses in RNase L–null
mice after HSV-1 infection, could help to elucidate the activity
of the 2–5A system during viral infection.
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